A one-time detection method for related substances in bisoprolol hydrochlorothiazide tablets

Through the combination of high-performance liquid chromatography and specific mobile phases and detection conditions, the one-time detection of five impurities in bisoprolol hydrochlorothiazide tablets is achieved, solving the problem of cumbersome and time-consuming detection in the prior art, and improving the detection efficiency and Resolution simplifies quality control.

CN118655253BActive Publication Date: 2024-11-12BEIJING WELLSO PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411095694.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-12
Publication Date
2024-11-12
Estimated Expiration
2044-08-12

AI Technical Summary

Technical Problem

The prior art requires at least two different detection methods when detecting impurities in bisoprolol hydrochlorothiazide tablets, resulting in cumbersome and time-consuming detection processes, and lack of convenient and efficient detection methods.

Method used

Using high performance liquid chromatography, a mixed solution of sodium dihydrogen phosphate/sodium octane sulfonate aqueous solution-Berry as the mobile phase, combined with specific detection conditions, such as the stationary phase is double-capped C18 and non-capped C18, flow rate It is 0.8-1.2mL/min, the column temperature is 30-40℃, and the detection wavelength is 223-225nm. Through the Agilent XDB-C18 chromatography column, five impurities in bisoprolol hydrochlorothiazide tablets can be detected at one time.

Benefits of technology

It greatly improves the detection efficiency, reduces the difficulty of detection, ensures accurate detection of impurities, improves separation, simplifies quality control, and has high industrial application value.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118655253B_ABST
    Figure CN118655253B_ABST
Patent Text Reader

Abstract

The present invention relates to testing or analyzing materials by means of measuring the chemical or physical properties of materials, mainly a drug analysis detection method, and in particular to a one-time detection method for related substances of bisoprolol hydrochlorothiazide tablets, the detection method comprising the following steps: step 1: preparing a test solution; step 2: using high performance liquid chromatography to detect related substances of bisoprolol hydrochlorothiazide tablets. The present invention replaces the common buffer salt in the mobile phase of the prior art with a mixed solution of an ion pair reagent sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution-acetonitrile, and at the same time, the present invention, by matching a specific mobile phase with specific detection conditions, can not only detect five impurities of two main active ingredients, bisoprolol and hydrochlorothiazide, at one time, but also greatly improve the separation between the related substances and between the related substances and the two main active ingredients during the detection process, and at the same time, the liquid phase baseline is more stable, so that the quality of the product can be better controlled.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of testing or analyzing materials by measuring the chemical or physical properties of the materials, and mainly relates to a drug analysis and detection method, in particular to a one-time detection method for related substances of bisoprolol hydrochlorothiazide tablets. Background Art

[0002] Bisoprolol is a new generation of selective β1 adrenergic receptor blockers, known for its high selectivity, and has become one of the first choice drugs for the treatment of essential hypertension and angina pectoris. Bisoprolol fumarate tablets are included in multiple pharmacopoeias and standards, including USP2023, EP11.0, BP2023, JP18, and the 2020 edition of the Chinese Pharmacopoeia. By comparing these different quality standards, we have summarized the relevant impurity information of bisoprolol fumarate tablets, as shown in the following table:

[0003]

[0004] As a widely recognized diuretic, hydrochlorothiazide tablets have been included in multiple authoritative pharmacopoeias, including USP2023, EP11.0, BP2023, JP18 and the 2020 edition of the Chinese Pharmacopoeia. In the process of synthesizing hydrochlorothiazide, there may be residual intermediate compounds, one of the main impurities is 4-amino-6-chloro-1,3-benzenedisulfonamide, whose structure is shown in the following table:

[0005]

[0006] Bisoprolol-HCT is a combination medicine that is commonly used to treat high blood pressure. The advantage of this combination medicine is that it can lower blood pressure at the same time through different mechanisms, which can improve the effectiveness of treatment: bisoprolol lowers blood pressure by slowing down the activity of the heart, while hydrochlorothiazide achieves its blood pressure-lowering effect by reducing the amount of fluid in the body.

[0007] Since there are many differences in the high performance liquid chromatography (HPLC) method for detecting the two main components and main impurities of bisoprolol and hydrochlorothiazide, including pretreatment steps, chromatographic column selection, mobile phase composition, system suitability, and detection wavelength selection, these factors are different, and we need at least 2 different detection methods to ensure that all impurities can be accurately detected. This complexity not only makes the detection process cumbersome, but also prolongs the detection time. Therefore, a more efficient and accurate substance detection method and system is urgently needed to improve the detection efficiency and separation. At present, in addition to the detection methods in the above-mentioned pharmacopoeia and import registration standards, there are no more convenient and efficient patents related to the detection method. However, due to the above-mentioned defects in the detection method in the pharmacopoeia and import registration standards, how to make the method for detecting related substances in bisoprolol hydrochlorothiazide tablets simpler and faster has become an urgent problem to be solved. Summary of the invention

[0008] The purpose of the present invention is to provide a one-time detection method for related substances of bisoprolol hydrochlorothiazide tablets in view of the deficiencies of the prior art, so as to solve the deficiency that two methods are required to detect all impurities in the prior art, provide more effective quality control, further improve the separation effect, and improve the industry standard.

[0009] The present invention provides a one-time detection method for related substances of bisoprolol hydrochlorothiazide tablets, and the detection method comprises the following steps:

[0010] Step 1: Prepare the test solution;

[0011] Step 2: Detecting the related substances of bisoprolol hydrochlorothiazide tablets by high performance liquid chromatography;

[0012] The detection conditions of the high performance liquid chromatography in step 2 include:

[0013] Mobile phase: a mixed solution of sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution-acetonitrile, wherein in the sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution, the concentration of sodium dihydrogen phosphate is 0.02-0.08 mol / L, the concentration of sodium octane sulfonate is 0.002-0.005 mol / L, and the volume ratio of sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution to acetonitrile is (75-80): (20-25);

[0014] Among them, the related substances include: (RS)-1-(4-hydroxymethyl-phenoxy)-3-isopropylamine isopropanol, 2-isopropoxyethyl-4[[(2RS)-2-hydroxy-3-(isopropylamino)propyl]oxy]benzoic acid, 4[{(2RS)-2-hydroxy-3-(isopropylamino)propyl}oxy]benzaldehyde, 4[{2-(1-methylethoxy)]ethoxy}methyl]phenol, and 4-amino-6-chloro-1,3-benzenedisulfonamide.

[0015] Furthermore, in step 2, the detection conditions of the high performance liquid chromatography also include: the stationary phase is double-end-capped C18 and unend-capped C18.

[0016] Furthermore, in step 2, the detection conditions of the high performance liquid chromatography also include: a flow rate of 0.8-1.2 mL / min.

[0017] Furthermore, in step 2, the detection conditions of the high performance liquid chromatography method also include: a column temperature of 30-40°C.

[0018] Furthermore, in step 2, the detection conditions of the high performance liquid chromatography also include: a detection wavelength of 223-225 nm.

[0019] Furthermore, in step 2, the detection conditions of the high performance liquid chromatography method further include:

[0020] Chromatographic column: Agilent XDB-C18, 4.6×250 mm, 5 μm.

[0021] Furthermore, in step 2, the detection conditions of the high performance liquid chromatography method further include:

[0022] Separation: The separation between the hydrochlorothiazide and bisoprolol peaks and the adjacent impurity peaks should be no less than 1.5.

[0023] Furthermore, in step 1, the preparation of the test solution includes the following steps:

[0024] Preparation of solvent A: add phosphoric acid dropwise into deionized water to adjust pH = 2, add acetonitrile and stir evenly, wherein the volume ratio of phosphoric acid aqueous solution to acetonitrile is (70-75): (25-30);

[0025] Preparation of the test solution: Take an appropriate amount of the bisoprolol hydrochlorothiazide tablets, grind them finely, weigh them accurately, add them to the solution A, shake and sonicate for 2-30 minutes until dissolved, make up to 28 g / L of the bisoprolol hydrochlorothiazide solution, filter with a 0.45 μm syringe filter membrane, and take the filtrate as the test solution.

[0026] Beneficial effects of the present invention

[0027] 1. The prior art generally uses phosphate buffer as a mobile phase to carry out quality control of bisoprolol hydrochlorothiazide tablets, and it is necessary to check four impurities in bisoprolol and one impurity in hydrochlorothiazide respectively, and at least two different detection methods are required to ensure that all impurities can be accurately detected, which leads to the problems that the detection method of related substances of bisoprolol hydrochlorothiazide tablets is cumbersome and time-consuming. The present invention adopts a mixed solution of an ion pair reagent sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution-acetonitrile as a mobile phase, and at the same time, through specific detection conditions, unexpectedly, it can detect five impurities in two main active ingredients, bisoprolol and hydrochlorothiazide tablets, at one time, which greatly improves the detection efficiency, reduces the detection difficulty, is easy to operate, and can ensure the safety of the product, and has extremely high industrial application value.

[0028] 2. The present invention, by combining a specific mobile phase with specific detection conditions, unexpectedly greatly improves the separation between the related substances and between the related substances and the two main active ingredients during the detection process. At the same time, the liquid phase baseline is also more stable, so that the quality of the product can be better controlled. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 This is a high performance liquid chromatogram of related substances of bisoprolol hydrochlorothiazide tablets in Example 1 of the present invention;

[0030] Figure 2 This is a high performance liquid chromatogram of related substances of bisoprolol hydrochlorothiazide tablets in Example 2 of the present invention;

[0031] Figure 3 This is a high performance liquid chromatogram of related substances of bisoprolol hydrochlorothiazide tablets in Example 3 of the present invention;

[0032] Figure 4 This is a high performance liquid chromatogram of related substances of bisoprolol hydrochlorothiazide tablets in Example 4 of the present invention;

[0033] Figure 5 This is the HPLC chromatogram of related substances of hydrochlorothiazide tablets in Comparative Example 1;

[0034] Figure 6 This is the HPLC chromatogram of related substances of bisoprolol fumarate tablets in Comparative Example 2. DETAILED DESCRIPTION

[0035] Example 1

[0036] Detection method of related substances in bisoprolol hydrochlorothiazide tablets:

[0037] Step 1: Prepare the test solution:

[0038] Prepare solvent A: add phosphoric acid dropwise into deionized water to adjust pH = 2, add acetonitrile and stir evenly, wherein the volume ratio of phosphoric acid aqueous solution to acetonitrile is 70:30;

[0039] Prepare the test solution: accurately weigh 280 mg of the ground bisoprolol hydrochlorothiazide tablets, place in a 10 mL volumetric flask, first add 8 mL of the solution A, shake and sonicate for 10 min, dilute to 10 mL, shake well, filter with a 0.45 μm syringe filter, and take the filtrate as the test solution;

[0040] Step 2: Detect the related substances of bisoprolol hydrochlorothiazide tablets by high performance liquid chromatography:

[0041] The test solution was injected into a high performance liquid chromatograph, and the detection conditions were as follows: mobile phase: a mixed solution of sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution-acetonitrile, wherein in the sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution, the concentration of sodium dihydrogen phosphate was 0.06 mol / L, the concentration of sodium octane sulfonate was 0.0025 mol / L, and the volume ratio of sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution to acetonitrile was 75:25; chromatographic column: Agilent XDB-C18, 4.6×250 mm, 5 μm; flow rate: 1.0 mL / min; column temperature: 35°C; detection wavelength: 223 nm;

[0042] Results: The resolution between hydrochlorothiazide and its adjacent impurity peaks was 2.18, and that between bisoprolol and its adjacent impurity peaks was 2.6.

[0043] Example 2

[0044] Detection method of related substances in bisoprolol hydrochlorothiazide tablets:

[0045] Step 1: Prepare the test solution:

[0046] Prepare solvent A: add phosphoric acid dropwise into deionized water to adjust pH = 2, add acetonitrile and stir evenly, wherein the volume ratio of phosphoric acid aqueous solution to acetonitrile is 70:30;

[0047] Prepare the test solution: accurately weigh 280 mg of the ground bisoprolol hydrochlorothiazide tablets, place in a 10 mL volumetric flask, first add 8 mL of the solution A, shake and sonicate for 10 min, dilute to 10 mL, shake well, filter with a 0.45 μm syringe filter, and take the filtrate as the test solution;

[0048] Step 2: Detect the related substances of bisoprolol hydrochlorothiazide tablets by high performance liquid chromatography:

[0049] The sample solution was injected into a high performance liquid chromatograph, and the detection conditions were as follows: mobile phase: a mixed solution of sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution-acetonitrile, wherein the concentration of sodium dihydrogen phosphate in the sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution was 0.06 mol / L, the concentration of sodium octane sulfonate was 0.0025 mol / L, and the volume ratio of sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution to acetonitrile was 80:20; chromatographic column: Agilent XDB- C18, 4.6×250 mm, 5 μm; flow rate: 1.0 mL / min; column temperature: 35°C; detection wavelength: 223 nm;

[0050] Results: The resolution between hydrochlorothiazide and adjacent impurity peaks was 2.15, and that between bisoprolol and adjacent impurity peaks was 2.53.

[0051] Example 3

[0052] Detection method of related substances in bisoprolol hydrochlorothiazide tablets:

[0053] Step 1: Prepare the test solution:

[0054] Prepare solvent A: add phosphoric acid dropwise into deionized water to adjust pH = 2, add acetonitrile and stir evenly, wherein the volume ratio of phosphoric acid aqueous solution to acetonitrile is 70:30;

[0055] Prepare the test solution: accurately weigh 280 mg of the ground bisoprolol hydrochlorothiazide tablets, place in a 10 mL volumetric flask, first add 8 mL of the solution A, shake and sonicate for 10 min, dilute to 10 mL, shake well, filter with a 0.45 μm syringe filter, and take the filtrate as the test solution;

[0056] Step 2: Detect the related substances of bisoprolol hydrochlorothiazide tablets by high performance liquid chromatography:

[0057] The sample solution was injected into a high performance liquid chromatograph, and the detection conditions were as follows: mobile phase: a mixed solution of sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution-acetonitrile, wherein the concentration of sodium dihydrogen phosphate in the sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution was 0.06 mol / L, the concentration of sodium octane sulfonate was 0.0025 mol / L, and the volume ratio of sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution to acetonitrile was 75:25; chromatographic column: Agilent XDB- C18, 4.6×250 mm, 5 μm; flow rate: 1.0 mL / min; column temperature: 30°C; detection wavelength: 223 nm;

[0058] Results: The resolution between hydrochlorothiazide and its adjacent impurity peaks was 2.17, and that between bisoprolol and its adjacent impurity peaks was 2.92.

[0059] Example 4

[0060] Detection method of related substances in bisoprolol hydrochlorothiazide tablets:

[0061] Step 1: Prepare the test solution:

[0062] Prepare solvent A: add phosphoric acid dropwise into deionized water to adjust pH = 2, add acetonitrile and stir evenly, wherein the volume ratio of phosphoric acid aqueous solution to acetonitrile is 70:30;

[0063] Prepare the test solution: accurately weigh 280 mg of the ground bisoprolol hydrochlorothiazide tablets, place in a 10 mL volumetric flask, first add 8 mL of the solution A, shake and sonicate for 10 min, dilute to 10 mL, shake well, filter with a 0.45 μm syringe filter, and take the filtrate as the test solution;

[0064] Step 2: Detect the related substances of bisoprolol hydrochlorothiazide tablets by high performance liquid chromatography:

[0065] The sample solution was injected into a high performance liquid chromatograph, and the detection conditions were as follows: mobile phase: a mixed solution of sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution-acetonitrile, wherein the concentration of sodium dihydrogen phosphate in the sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution was 0.06 mol / L, the concentration of sodium octane sulfonate was 0.0025 mol / L, and the volume ratio of sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution to acetonitrile was 75:25; chromatographic column: Agilent XDB- C18, 4.6×250 mm, 5 μm; flow rate: 1.1 mL / min; column temperature: 35°C; detection wavelength: 223 nm;

[0066] Results: The resolution between hydrochlorothiazide and its adjacent impurity peaks was 2.4, and that between bisoprolol and its adjacent impurity peaks was 3.26.

[0067] Comparative Example 1:

[0068] Detection method for related substances in hydrochlorothiazide tablets:

[0069] Step 1: Prepare the test solution:

[0070] Prepare solvent A: add 100 mL of acetonitrile to 100 mL of methanol and stir evenly;

[0071] Prepare the test solution: accurately weigh 0.1 g of the ground hydrochlorothiazide tablets, place in a 10 mL volumetric flask, first add 8 mL of the solvent A, shake and sonicate for 10 min, make up to 10 mL, shake well, filter with a 0.45 μm syringe filter membrane, and take the filtrate as the test solution;

[0072] Step 2: Detection of related substances in hydrochlorothiazide tablets by high performance liquid chromatography:

[0073] The test solution was injected into the high performance liquid chromatograph, and the detection conditions were as follows: mobile phase A: a mixed solution of water, methanol, and tetrahydrofuran, wherein the volume ratio of water, methanol, and tetrahydrofuran was 94:6:1; mobile phase B: a mixed solution of water, methanol, and tetrahydrofuran, wherein the volume ratio of water, methanol, and tetrahydrofuran was 50:50:5; chromatographic column: Agilent XDB-C18, 4.6×250mm, 5μm; flow rate: 1.0mL / min; column temperature: 25℃; detection wavelength: 224nm;

[0074] Results: The resolution of hydrochlorothiazide and adjacent impurity peaks was 2.13.

[0075] Comparative Example 2:

[0076] Detection method of related substances in bisoprolol fumarate tablets:

[0077] Step 1: Prepare the test solution:

[0078] Solvent: Water

[0079] Prepare the test solution: accurately weigh 280 mg of the ground bisoprolol fumarate tablets, place in a 10 mL volumetric flask, first add 8 mL of the solution water, shake and ultrasonicate for 10 min, dilute to 10 mL, shake well, filter with a 0.45 μm syringe filter membrane, and take the filtrate as the test solution;

[0080] Step 2: Detect the related substances in bisoprolol fumarate tablets by high performance liquid chromatography:

[0081] The sample solution was injected into a high performance liquid chromatograph, and the detection conditions were as follows: mobile phase: a mixed solution of ammonium dihydrogen phosphate and acetonitrile, wherein the concentration of ammonium dihydrogen phosphate was 0.05 mol / L, and the volume ratio of ammonium dihydrogen phosphate to acetonitrile was 70:30; chromatographic column: Agilent XDB-C18, 4.6×250 mm, 5 μm; flow rate: 1.0 mL / min; column temperature: 35°C; detection wavelength: 225 nm;

[0082] Results: The resolution of bisoprolol fumarate tablets and adjacent impurity peaks was 2.02.

[0083] By adopting the detection method of the present invention, all impurities can be effectively detected, and the separation between impurities and between impurities and main active substances can be ensured to be better than that of individual determination and the separation of components determined by the prior art, and the detection method of the present invention can be selected to better control the quality of the product.

Claims

1. A one-time detection method for related substances in bisoprolol hydrochlorothiazide tablets, characterized in that: The detection method comprises the following steps: Step 1: Prepare the test solution; Step 2: Detecting the related substances of bisoprolol hydrochlorothiazide tablets by high performance liquid chromatography; The detection conditions of the high performance liquid chromatography in step 2 include: Mobile phase: a mixed solution of sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution-acetonitrile, wherein in the sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution, the concentration of sodium dihydrogen phosphate is 0.02-0.08 mol / L, the concentration of sodium octane sulfonate is 0.002-0.005 mol / L, and the volume ratio of sodium dihydrogen phosphate / sodium octane sulfonate aqueous solution to acetonitrile is (75-80): (20-25); The related substances include: (RS)-1-(4-hydroxymethyl-phenoxy)-3-isopropylamine isopropanol, 2-isopropoxyethyl-4[[(2RS)-2-hydroxy-3-(isopropylamino)propyl]oxy]benzoic acid, 4[{(2RS)-2-hydroxy-3-(isopropylamino)propyl}oxy]benzaldehyde, 4[{2-(1-methylethoxy)]ethoxy}methyl]phenol, and 4-amino-6-chloro-1,3-benzenedisulfonamide.

2. The method according to claim 1, characterized in that In the step 2, the detection conditions of the high performance liquid chromatography also include: the stationary phase is double-end-capped C18 and unend-capped C18.

3. The method according to claim 1, characterized in that In step 2, the detection conditions of the high performance liquid chromatography also include: a flow rate of 0.8-1.2 mL / min.

4. The method according to claim 1, characterized in that: In step 2, the detection conditions of the high performance liquid chromatography also include: a column temperature of 30-40°C.

5. The method according to claim 1, characterized in that In step 2, the detection conditions of the high performance liquid chromatography also include: the detection wavelength is 223-225nm.

6. The method according to claim 1, characterized in that In step 2, the detection conditions of the high performance liquid chromatography also include: chromatographic column: Agilent XDB-C18, 4.6×250 mm, 5 μm.

7. The method according to claim 1, characterized in that In step 2, the detection conditions of the high performance liquid chromatography also include: separation degree: the separation degree between the hydrochlorothiazide and bisoprolol peaks and the adjacent impurity peaks should be no less than 1.

5.

8. The method according to claim 1, wherein in step 1, the preparation of the test solution comprises the following steps: Preparation of solvent A: add phosphoric acid dropwise into deionized water to adjust pH = 2, add acetonitrile and stir evenly, wherein the volume ratio of phosphoric acid aqueous solution to acetonitrile is (70-75): (25-30); Preparation of the test solution: Take an appropriate amount of the bisoprolol hydrochlorothiazide tablets, grind them finely, weigh them accurately, add them into the solution A, shake and sonicate for 2-30 min until dissolved, make up to 28 g / L bisoprolol hydrochlorothiazide solution, filter with a 0.45 μm syringe filter membrane, and take the filtrate as the test solution.